Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075392 | SCV001241014 | likely pathogenic | Retinal dystrophy | 2018-07-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001205880 | SCV001377160 | pathogenic | not provided | 2023-12-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile3103Leufs*57) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 866968). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003455412 | SCV004182715 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003455412 | SCV005055746 | likely pathogenic | Retinitis pigmentosa 39 | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005021431 | SCV005645081 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2024-06-06 | criteria provided, single submitter | clinical testing |